210 related articles for article (PubMed ID: 33579362)
1. Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway.
Shu X; Cao KY; Liu HQ; Yu L; Sun LX; Yang ZH; Wu CA; Ran YL
Stem Cell Res Ther; 2021 Feb; 12(1):119. PubMed ID: 33579362
[TBL] [Abstract][Full Text] [Related]
2. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
[TBL] [Abstract][Full Text] [Related]
3. HSP90, as a functional target antigen of a mAb 11C9, promotes stemness and tumor progression in hepatocellular carcinoma.
Liu HQ; Sun LX; Yu L; Liu J; Sun LC; Yang ZH; Shu X; Ran YL
Stem Cell Res Ther; 2023 Sep; 14(1):273. PubMed ID: 37759328
[TBL] [Abstract][Full Text] [Related]
4. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
5. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
6. Targeting Endothelial ENO1 (Alpha-Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension.
Shi Y; Liu J; Zhang R; Zhang M; Cui H; Wang L; Cui Y; Wang W; Sun Y; Wang C
Hypertension; 2023 May; 80(5):1035-1047. PubMed ID: 37075135
[TBL] [Abstract][Full Text] [Related]
7. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies targeting non-small cell lung cancer stem-like cells by multipotent cancer stem cell monoclonal antibody library.
Cao K; Pan Y; Yu L; Shu X; Yang J; Sun L; Sun L; Yang Z; Ran Y
Int J Oncol; 2017 Feb; 50(2):587-596. PubMed ID: 28035349
[TBL] [Abstract][Full Text] [Related]
9. Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis.
Yang T; Shu X; Zhang HW; Sun LX; Yu L; Liu J; Sun LC; Yang ZH; Ran YL
Cell Death Dis; 2020 Oct; 11(10):870. PubMed ID: 33067426
[TBL] [Abstract][Full Text] [Related]
10. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F
J Hematol Oncol; 2017 Jan; 10(1):16. PubMed ID: 28086938
[TBL] [Abstract][Full Text] [Related]
11. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.
Chang GC; Liu KJ; Hsieh CL; Hu TS; Charoenfuprasert S; Liu HK; Luh KT; Hsu LH; Wu CW; Ting CC; Chen CY; Chen KC; Yang TY; Chou TY; Wang WH; Whang-Peng J; Shih NY
Clin Cancer Res; 2006 Oct; 12(19):5746-54. PubMed ID: 17020980
[TBL] [Abstract][Full Text] [Related]
12. Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
Cancemi P; Buttacavoli M; Roz E; Feo S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416219
[TBL] [Abstract][Full Text] [Related]
13. ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling-Driven Epithelial-to-Mesenchymal Transition.
Li HJ; Ke FY; Lin CC; Lu MY; Kuo YH; Wang YP; Liang KH; Lin SC; Chang YH; Chen HY; Yang PC; Wu HC
Cancer Res; 2021 Aug; 81(15):4094-4109. PubMed ID: 34145039
[TBL] [Abstract][Full Text] [Related]
14. Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1-mediated glycolysis reprogramming.
Tang C; Zhang H; Deng WS; Xiong LQ; Zhou LQ
Kaohsiung J Med Sci; 2023 Sep; 39(9):904-915. PubMed ID: 37334727
[TBL] [Abstract][Full Text] [Related]
15. Anti-ENO1 antibody combined with metformin against tumor resistance: a novel antibody-based platform.
Shu X; Zhang HW; Liu SY; Sun LX; Zhang T; Ran YL
PeerJ; 2024; 12():e16817. PubMed ID: 38515460
[TBL] [Abstract][Full Text] [Related]
16. microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway.
Guo JC; Yang YJ; Zhang JQ; Guo M; Xiang L; Yu SF; Ping H; Zhuo L
J Cell Physiol; 2019 Dec; 234(12):23461-23474. PubMed ID: 31232474
[TBL] [Abstract][Full Text] [Related]
17. The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.
Ryans K; Omosun Y; McKeithen DN; Simoneaux T; Mills CC; Bowen N; Eko FO; Black CM; Igietseme JU; He Q
BMC Immunol; 2017 May; 18(1):27. PubMed ID: 28525970
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of α-enolase affects the biological activity of breast cancer cells by attenuating PI3K/Akt signaling pathway.
Zang HY; Gong LG; Li SY; Hao JG
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):249-257. PubMed ID: 31957838
[TBL] [Abstract][Full Text] [Related]
19. Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.
Sun L; Lu T; Tian K; Zhou D; Yuan J; Wang X; Zhu Z; Wan D; Yao Y; Zhu X; He S
Eur J Pharmacol; 2019 Feb; 845():8-15. PubMed ID: 30582908
[TBL] [Abstract][Full Text] [Related]
20. ENO1 promotes immunosuppression and tumor growth in pancreatic cancer.
Huang CK; Lv L; Chen H; Sun Y; Ping Y
Clin Transl Oncol; 2023 Jul; 25(7):2250-2264. PubMed ID: 36820953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
